Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma

Saved in:
Bibliographic Details
Published in:RevSALUS Vol. 4; no. Sup
Main Authors: Filipa Amaro, Carolina Pisoeiro, Maria João Valente, Vera Miranda-Gonçalves, Carmen Jerónimo, Rui Henrique, Maria de Lourdes Bastos, Paula Guedes de Pinho, Márcia Carvalho, Joana Pinto
Format: Journal Article
Language:English
Published: Rede Académica das Ciências da Saúde da Lusofonia - RACS 01-04-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Author Carolina Pisoeiro
Rui Henrique
Carmen Jerónimo
Maria de Lourdes Bastos
Maria João Valente
Vera Miranda-Gonçalves
Filipa Amaro
Joana Pinto
Paula Guedes de Pinho
Márcia Carvalho
Author_xml – sequence: 1
  fullname: Filipa Amaro
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
– sequence: 2
  fullname: Carolina Pisoeiro
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
– sequence: 3
  fullname: Maria João Valente
  organization: National Food Institute, Technical University of Denmark, Kongens Lyngby, Copenhagen, Denmark
– sequence: 4
  fullname: Vera Miranda-Gonçalves
  organization: Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal
– sequence: 5
  fullname: Carmen Jerónimo
  organization: Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal
– sequence: 6
  fullname: Rui Henrique
  organization: Cancer Biology & Epigenetics Group–Research Centre, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal. Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar–University of Porto, Porto, Portugal
– sequence: 7
  fullname: Maria de Lourdes Bastos
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
– sequence: 8
  fullname: Paula Guedes de Pinho
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
– sequence: 9
  fullname: Márcia Carvalho
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. FP-I3ID, FP-BHS, University Fernando Pessoa, Porto, Portugal. Faculty of Health Sciences, Fernando Pessoa University, Porto, Portugal
– sequence: 10
  fullname: Joana Pinto
  organization: Associate Laboratory i4HB, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal. UCIBIO-REQUIMTE, Department of Biological Sciences, Laboratory of Toxicology, Faculty of Pharmacy, University of Porto, Portugal
BookMark eNqtkDlOxDAYhS00SAwwN6DwBSZ4GyepWQQ1FHTRP14iD44deRkJTk9AOQLVe-8rvuJdo02IwSB0R0lzoJTJ-2TOGXzNzVm4tzo3gtALtGW0E_uOy4_N2kUnyRXa5XwihLCe8Y6JLfp8dNaaZEJx4LEy3lcPCZsFqpJxtDjX4IoL7oghaDzDd5zhdxVIoylGY53qmLGNCU-mQC5QnMKLcfVhBUm5ECe4RZcWfDa7NW_Q6_PT-8PLXkc4DXNyE6SvIYIb_kBM4wBpkXkz0F4xODDLu5YLImVvNdOt5G1_5HS5gf-n6wfg525q
ContentType Journal Article
DBID DOA
DOI 10.51126/revsalus.v4iSup.401
DatabaseName Directory of Open Access Journals
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
EISSN 2184-836X
ExternalDocumentID oai_doaj_org_article_19c2a52f387340669fd2d76379b31511
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
GROUPED_DOAJ
ID FETCH-doaj_primary_oai_doaj_org_article_19c2a52f387340669fd2d76379b315113
IEDL.DBID DOA
ISSN 2184-4860
IngestDate Tue Oct 22 15:13:41 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Issue Sup
Language English
LinkModel DirectLink
MergedId FETCHMERGED-doaj_primary_oai_doaj_org_article_19c2a52f387340669fd2d76379b315113
OpenAccessLink https://doaj.org/article/19c2a52f387340669fd2d76379b31511
ParticipantIDs doaj_primary_oai_doaj_org_article_19c2a52f387340669fd2d76379b31511
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationTitle RevSALUS
PublicationYear 2022
Publisher Rede Académica das Ciências da Saúde da Lusofonia - RACS
Publisher_xml – name: Rede Académica das Ciências da Saúde da Lusofonia - RACS
SSID ssj0002923824
Score 3.681008
SourceID doaj
SourceType Open Website
SubjectTerms antiproliferative
cytotoxicity
in vitro
renal cell carcinoma
tyrosine kinase inhibitors
Title Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma
URI https://doaj.org/article/19c2a52f387340669fd2d76379b31511
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV09T8MwELWgEwsCAeJbN7CmBDtO4xFoq7KwlIEt8ldQRJtESdOBX4_PjlA3Bhjj4WJd5Ny987t7hNxxIX3a7WCJ4FGiEx2p1FfEhMMjisXSYMFtsZy8vmfTGY7J-ZH6Qk5YGA8cHHf_IDSVnBYsmzAXfFJRGGrcoZgIxVy0CsAnTnfAFP6DqctbMq9oixAmQqWl0DfHfctMa7edXPXdeJuUy74ZJ6gJszOz3weX-RE5HLJCeAy7OSZ7tjohn9NBvMQdwhVghR0pozAwMKAuoOuR-lOVCmRloJFfDgHjU6B3WwOm7T86cHkprO1GYvNQqcFZHOyBRiWhql7LU_Iyn709LyLcXd6EERQ5DoX2C85V-eCq_DdXsTMyqurKnhMQXEoHXSi3Kk201EJyboXWjMYKrwovyNPf33f5H0auyAHFjgNPlrkmo03b2xuy35n-1n_yb8Mbs38
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+cellular+effects+of+sunitinib+and+pazopanib+targeted+drugs+for+metastatic+renal+cell+carcinoma&rft.jtitle=RevSALUS&rft.au=Filipa+Amaro&rft.au=Carolina+Pisoeiro&rft.au=Maria+Jo%C3%A3o+Valente&rft.au=Vera+Miranda-Gon%C3%A7alves&rft.date=2022-04-01&rft.pub=Rede+Acad%C3%A9mica+das+Ci%C3%AAncias+da+Sa%C3%BAde+da+Lusofonia+-+RACS&rft.issn=2184-4860&rft.eissn=2184-836X&rft.volume=4&rft.issue=Sup&rft_id=info:doi/10.51126%2Frevsalus.v4iSup.401&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_19c2a52f387340669fd2d76379b31511
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2184-4860&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2184-4860&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2184-4860&client=summon